Skip Navigation

Nicotine & Tobacco Research 2004 6(6):1009-1014; doi:10.1080/14622200412331324949
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fang, Q.
Right arrow Articles by Mayhan, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, Q.
Right arrow Articles by Mayhan, W. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Society for Research on Nicotine and Tobacco

L-Arginine prevents impaired endothelium-dependent cerebral arteriolar dilatation during acute infusion of nicotine

Qin Fang, M.D., Hong Sun, M.D., Ph.D. and William G. Mayhan, Ph.D.

Department of Cellular and Integrative Physiology, University of Nebraska Medical Center Omaha, NE

Correspondence: William G. Mayhan, Ph.D., Department of Cellular and Integrative Physiology, 985850 Nebraska Medical Center, Omaha, NE 68198-5850, USA. Tel.: +1 (402)-559-5329; Fax: +1 (402)-559-4438; E-mail: wgmayhan{at}unmc.edu


   Abstract

Exogenous treatment with L-arginine has been shown to restore impaired nitric oxide synthase (NOS)-dependent dilatation of peripheral blood vessels during disease states. We have shown that nicotine impairs NOS-dependent arteriolar dilatation in the cerebral circulation. However, the role of L-arginine in impaired responses of cerebral arterioles during infusion of nicotine has not been examined. Thus the goal of the present study was to examine the role of L-arginine in nicotine-induced impairment of cerebral arteriolar reactivity. We measured the diameter of pial arterioles in response to NOS-dependent (5'-adenosine diphosphate [ADP] and acetylcholine) and NOS-independent (nitroglycerin) agonists before and after infusion of vehicle or nicotine (2 µg/kg/min intravenously for 30 min followed by a maintenance dose of 0.35 µg/kg/min) in the absence or presence of L-arginine (10–3 M). We found that topical application of L-arginine to cerebral microvessels during infusion of nicotine could prevent impaired NOS-dependent vasodilatation. We suggest that exogenous L-arginine may have a beneficial role in preventing cerebral microvascular dysfunction during exposure to nicotine.

Received: February 17, 2003; Accepted: July 2, 2003
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
H. Iida, M. Iida, M. Takenaka, N. Fukuoka, and S. Dohi
Rho-kinase inhibitor and Nicotinamide Adenine Dinucleotide PHosphate oxidase inhibitor prevent impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 89 - 94.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
D. M. Arrick and W. G. Mayhan
Acute infusion of nicotine impairs nNOS-dependent reactivity of cerebral arterioles via an increase in oxidative stress
J Appl Physiol, December 1, 2007; 103(6): 2062 - 2067.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Q. Fang, H. Sun, D. M. Arrick, and W. G. Mayhan
Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine
J Appl Physiol, February 1, 2006; 100(2): 631 - 636.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.